271 related articles for article (PubMed ID: 36382475)
21. Mesenchymal stem cells and immune disorders: from basic science to clinical transition.
Wang S; Zhu R; Li H; Li J; Han Q; Zhao RC
Front Med; 2019 Apr; 13(2):138-151. PubMed ID: 30062557
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.
Beghini DG; Horita SI; Henriques-Pons A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685567
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():2938. PubMed ID: 30619298
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease.
Yuan M; Hu X; Yao L; Jiang Y; Li L
Stem Cell Res Ther; 2022 May; 13(1):179. PubMed ID: 35505419
[TBL] [Abstract][Full Text] [Related]
26. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials.
Tappenbeck N; Schröder HM; Niebergall-Roth E; Hassinger F; Dehio U; Dieter K; Kraft K; Kerstan A; Esterlechner J; Frank NY; Scharffetter-Kochanek K; Murphy GF; Orgill DP; Beck J; Frank MH; Ganss C; Kluth MA
Cytotherapy; 2019 May; 21(5):546-560. PubMed ID: 30878384
[TBL] [Abstract][Full Text] [Related]
27. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
28. Novel Mesenchymal Stem Cell Spheroids with Enhanced Stem Cell Characteristics and Bone Regeneration Ability.
Ohori-Morita Y; Niibe K; Limraksasin P; Nattasit P; Miao X; Yamada M; Mabuchi Y; Matsuzaki Y; Egusa H
Stem Cells Transl Med; 2022 Apr; 11(4):434-449. PubMed ID: 35267026
[TBL] [Abstract][Full Text] [Related]
29. Human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis via regulation of B lymphocyte maturation.
Shin TH; Lee BC; Choi SW; Shin JH; Kang I; Lee JY; Kim JJ; Lee HK; Jung JE; Choi YW; Lee SH; Yoon JS; Choi JS; Lee CS; Seo Y; Kim HS; Kang KS
Oncotarget; 2017 Jan; 8(1):512-522. PubMed ID: 27888809
[TBL] [Abstract][Full Text] [Related]
30. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
Xie Q; Liu R; Jiang J; Peng J; Yang C; Zhang W; Wang S; Song J
Stem Cell Res Ther; 2020 Dec; 11(1):519. PubMed ID: 33261658
[TBL] [Abstract][Full Text] [Related]
31. Will mesenchymal stem cells be future directions for treating radiation-induced skin injury?
Fang Z; Chen P; Tang S; Chen A; Zhang C; Peng G; Li M; Chen X
Stem Cell Res Ther; 2021 Mar; 12(1):179. PubMed ID: 33712078
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints.
Kim EY; Kim HS; Hong KS; Chung HM; Park SP; Noh G
Stem Cell Res Ther; 2021 Oct; 12(1):539. PubMed ID: 34635172
[TBL] [Abstract][Full Text] [Related]
33. Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation.
Jo H; Brito S; Kwak BM; Park S; Lee MG; Bin BH
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673711
[TBL] [Abstract][Full Text] [Related]
34. Human adipose tissue-derived MSCs improve psoriasis-like skin inflammation in mice by negatively regulating ROS.
Shi F; Guo LC; Zhu WD; Cai MH; Chen LL; Wu L; Chen XJ; Zhu HY; Wu J
J Dermatolog Treat; 2022 Jun; 33(4):2129-2136. PubMed ID: 34060412
[TBL] [Abstract][Full Text] [Related]
35. Disease-specific primed human adult stem cells effectively ameliorate experimental atopic dermatitis in mice.
Lee BC; Kim JJ; Lee JY; Kang I; Shin N; Lee SE; Choi SW; Cho JY; Kim HS; Kang KS
Theranostics; 2019; 9(12):3608-3621. PubMed ID: 31281501
[TBL] [Abstract][Full Text] [Related]
36. Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
Maria ATJ; Toupet K; Maumus M; Rozier P; Vozenin MC; Le Quellec A; Jorgensen C; Noël D; Guilpain P
Front Immunol; 2018; 9():2571. PubMed ID: 30455706
[No Abstract] [Full Text] [Related]
37. Novel therapies using cell sheets engineered from allogeneic mesenchymal stem/stromal cells.
Kondo M; Kameishi S; Grainger DW; Okano T
Emerg Top Life Sci; 2020 Dec; 4(6):677-689. PubMed ID: 33231260
[TBL] [Abstract][Full Text] [Related]
38. EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment.
Zhang X; Ren Z; Jiang Z
Mol Cell Biochem; 2023 Apr; 478(4):755-765. PubMed ID: 36083511
[TBL] [Abstract][Full Text] [Related]
39. Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies.
Kim HS; Lee JH; Roh KH; Jun HJ; Kang KS; Kim TY
Stem Cells; 2017 Jan; 35(1):248-255. PubMed ID: 27256706
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
